Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Congressional Testimony

Congressional Testimony

                        Congressional Testimony 2018 - 2019
          Congressional Testimony  2017
          Congressional Testimony 2016 Home
          News & Events
          Congressional Testimony
          Oral Testimony of FDA Commissioner Robert M. Califf, M.D., on the FDA Foods Program - 07/20/2022Congressional Testimony Testimony
    Event Title
              Oral Testimony of FDA Commissioner Robert M. Califf, M.D., on the FDA Foods Program


                  July 20, 2022

  

             Before the Subcommittee on Agriculture, Rural Development,   Food and Drug Administration, and Related Agencies , Committee on Appropriations, U.S. Senate
  
  Share
    Post
    Linkedin

    Email
    PrintTestimony of 
                    
          Robert M. Califf, M.D., MACC  Commissioner of Food and Drugs - Food and Drug Administration   

 




*(Remarks as prepared for delivery)*

Chair Baldwin, Ranking Member Hoeven, and members of the Committee.  Thank you for inviting us to testify about food safety and the Food and Drug Administration’s Foods Program.
 
I want to assure you that the safety of our nation’s food supply is one of my absolute top priorities.  Although foodborne outbreaks continue to occur, all experts with whom I have consulted agree that America’s food supply has never been safer than it is today. But as the industry, the environment, and the international landscape change, we must prepare for future challenges.

As envisioned in the New Era of Smarter Food Safety, the combination of tech-enabled traceability, smarter tools for prevention and response, new business models and retail modernization and a collaborative food safety culture where industry is implementing the preventive framework envisioned by FSMA, paint an exciting picture for the future.

The recent acceleration of digital technologies enabling traceability and predictive capabilities, innovation in genomics facilitating outbreak response, and advances in agricultural biotechnology that allow food production to resist the effects of climate change and feed the growing global population bring that vision even closer within reach.

Further, food is the foundation of health. Smarter food safety, better nutrition, and ongoing efforts to reduce environmental contaminants and toxins in our food supply are critical for improved health of the whole U.S. population.

I anticipate a future in which people have more reliably safe food, more access to variety and certainty about availability; and the agricultural ecosystem thrives, enabling it to feed the U.S. and the world.  To realize this future, we must reexamine and reinvent the ways we approach our food safety and nutrition work.

During my confirmation, I was contacted by multiple experts and concerned groups about the perception that the FDA’s Foods Program is not adequately organized or supported.

In my first five months back in the job I’ve met with stakeholders and experts to discuss FDA’s Foods Program and food policy priorities for the next decade. My assessment is that the Foods Program is staffed by highly dedicated people; I can’t stress enough how hard they work and the depth of their knowledge.  But they are working in a suboptimal environment that needs to be reformed.

Accordingly, we have initiated a full review of the Foods Program, including its structure, function, leadership, authorities and funding.  I want to assure you that I intend to communicate about and implement any organizational and strategic changes that will further improve the performance of the Agency’s Foods Program.

Several key issues must be addressed, and we will not wait for the results of the full assessment to get started:

Hiring and retaining Foods Program staff has long been a concern.  I am grateful that the user fee reauthorization bills in both Chambers recognize the great need to get the right staff on board quickly.
	Failures of the supply chain throughout the pandemic, and particularly the recent infant formula crisis, have shown the importance of new authorities FDA seeks to anticipate and respond to supply shortages.
	As the world moves to digitize its information, the Foods Program must upgrade its technology and modernize its work processes to enable its workforce to be maximally productive, using machine learning and virtual methods to keep up with the vast and rapidly expanding foods ecosystem.
	Food contamination and recall events will always capture the headlines, but we must balance the food safety plan with work on nutritional science and labeling that enables consumers to make informed dietary choices and facilitates industry reformulation.  When FDA added trans-fat to the Nutrition Facts label, intake decreased by 80%.  The results of FDA’s nutrition work go largely unseen, only becoming evident through generations of health data, yet turning the tide on diet-related chronic disease is a critical priority for me and this administration because of the potential to impact the health of every American, dramatically reduce health care costs and close our life expectancy gap—currently five (5) years shorter than the average of other high-income countries.As we work together to implement needed changes, and identify critical gaps in authorities or resources, I will continue to engage with Congress as we all share the same goals of a safer food supply.

In conclusion, our food has never been safer, yet challenges remain, and we must do better.  One food outbreak is one too many.  I appreciate your attention to this and look forward to continuing to work with you to ensure the Foods Program at FDA has the right structure, people, budget, and authority to keep our food supply safe.

                                                                                  Content current as of:
      07/20/2022More Congressional
      Testimonies

        
        Congressional Testimony

          
                        Congressional Testimony 2018 - 2019
          Congressional Testimony  2017
          Congressional Testimony 2016
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop